Publications by authors named "Jiling Niu"

Claim this Profile
P
Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: a propensity score-matched study.
Zhuoran Sun, Yingfan Guo, Shuangqing Lu, Jiling Niu, Qinhao Xu

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.
Runze Liu, Xiaokang Guo, Guangjian Yang, Shuangqing Lu, Feihu Chen, Jiling Niu

J Hazard Mater· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of a nomogram to guide prophylactic cranial irradiation in extensive‑stage small cell lung cancer.
Haoyu Liu, Feihu Chen, Qinhao Xu, Xiaoyang Zhai, Yaru Tian, Jiling Niu

Oncol Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes.
Xuquan Jing, Min Wang, Shuangqing Lu, Jiling Niu, Feihu Chen

BMC Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions.
Yana Qi, Dongmei Sun, Xiaoyang Zhai, Feihu Chen, Jiling Niu

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer.
Ke Zhao, Shuangqing Lu, Jiling Niu, Hui Zhu, Yaru Tian

BMC Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of circular RNAs in cancer therapy resistance.
Wenjuan Liu, Jiling Niu, Yanfei Huo, Long Zhang, Linyu Han

Mol Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong PD-L1 affect clinical outcomes in advanced NSCLC treated with third-generation EGFR-TKIs.
Jiling Niu, Xuquan Jing, Qinhao Xu, Haoyu Liu, Yaru Tian

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
Feihu Chen, Jiling Niu, Min Wang, Hui Zhu, Zhijun Guo

Radiat Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study.
Shuangqing Lu, Xiaokang Guo, Zhengqiang Yang, Yulan Sun, Jiling Niu

Future Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy.
Feihu Chen, Jiling Niu, Min Wang, Hui Zhu, Zhijun Guo

J Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis